Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNN4 | O15554 | 3/20 | 0.47 |
| ▸ | KCNA5 | P22460 | 3/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | RECQL | P46063 | 1/20 | 0.42 |
| ▸ | SRC | P12931 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CA4 | P22748 | 1/20 | 0.41 |
| ▸ | CA5A | P35218 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30266099 | 1.00 | KCNN4 (0.47) | KCNN4KCNA5L3MBTL1ALDH1A1NPC1 | |
| SCHEMBL28980065 | 0.86 | ALDH1A1 (0.48) | KCNN4KCNA5L3MBTL1ALDH1A1NPC1 | |
| SCHEMBL28980085 | 0.86 | ALDH1A1 (0.48) | KCNN4KCNA5L3MBTL1ALDH1A1NPC1 | |
| SCHEMBL28980069 | 0.83 | ACP3 (0.56) | L3MBTL1ALDH1A1NPC1HTTNPSR1 | |
| SCHEMBL30265981 | 0.83 | ACP3 (0.54) | KCNN4KCNA5L3MBTL1ALDH1A1NPC1 | |
| SCHEMBL28980066 | 0.83 | L3MBTL1 (0.46) | KCNN4KCNA5L3MBTL1ALDH1A1NPC1 | |
| SCHEMBL28980071 | 0.83 | ACP3 (0.56) | L3MBTL1ALDH1A1NPC1HTTNPSR1 | |
| SCHEMBL28980038 | 0.83 | L3MBTL1 (0.46) | KCNN4KCNA5L3MBTL1ALDH1A1NPC1 | |
| SCHEMBL18486440 | 0.82 | ALDH1A1 (0.47) | KCNN4KCNA5L3MBTL1ALDH1A1NPC1 | |
| SCHEMBL28980099 | 0.82 | IDO1 (0.42) | KCNN4KCNA5L3MBTL1ALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116217395-A | Preparation method of beta-carbonyl compound | 黄淮学院 | 2023-06-06 | — | — | CN | disclosed |
| US-10103401-B2 | Polymer electrolyte composition and polymer electrolyte membrane, polymer electrolyte membrane with catalyst layer, membrane electrode assembly, and polymer electrolyte fuel cell each using the same | TORAY INDUSTRIES, INC. (JP) | 2018-10-16 | — | — | US | disclosed |
| EP-3131145-B1 | POLYMER ELECTROLYTE COMPOSITION AND POLYMER ELECTROLYTE MEMBRANE, MEMBRANE-ELECTROLYTE ASSEMBLY, AND SOLID POLYMER FUEL CELL USING SAME | TORAY INDUSTRIES (JP) | 2018-09-05 | — | — | EP | disclosed |
| US-20170125832-A1 | POLYMER ELECTROLYTE COMPOSITION AND POLYMER ELECTROLYTE MEMBRANE, POLYMER ELECTROLYTE MEMBRANE WITH CATALYST LAYER, MEMBRANE ELECTRODE ASSEMBLY, AND POLYMER ELECTROLYTE FUEL CELL EACH USING THE SAME | TORAY INDUSTRIES, INC. (JP) | 2017-05-04 | — | — | US | disclosed |
| EP-3131145-A1 | POLYMER ELECTROLYTE COMPOSITION AND POLYMER ELECTROLYTE MEMBRANE, MEMBRANE-ELECTROLYTE ASSEMBLY, AND SOLID POLYMER FUEL CELL USING SAME | Toray Industries, Inc. (JP) | 2017-02-15 | — | — | EP | disclosed |
| CN-102803349-A | Silicone hydrogels formed from symmetric hydroxyl functionalized siloxanes | JOHNSON & JOHNSON VISION CARE | 2012-11-28 | — | — | CN | disclosed |
| US-7465838-B2 | Chiral diols, their manufacture and ligands and catalysts derived therefrom | CIBA SPECIALTY CHEMICAL CORP. (US) | 2008-12-16 | — | — | US | disclosed |
| US-20060030737-A1 | Chiral diols, their manufacture and ligands and catalysts derived therefrom | CIBA SPECIALTY CHEMICALS CORP. | 2006-02-09 | — | — | US | disclosed |
| EP-1582527-A1 | Synthesis of phosphorus based ligands | Ciba SC Holding AG (CH) | 2005-10-05 | — | — | EP | disclosed |
| EP-1546077-A2 | CHIRAL DIOLS, THEIR MANUFACTURE AND LIGANDS AND CATALYSTS DERIVED THEREFROM | Ciba SC Holding AG (CH) | 2005-06-29 | — | — | EP | disclosed |
| WO-2004031109-A2 | CHIRAL DIOLS, THEIR MANUFACTURE AND LIGANDS AND CATALYSTS DERIVED THEREFROM | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2004-04-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060030737-A1 | Chiral diols, their manufacture and ligands and catalysts derived therefrom | B2M, CYP4F11, CYP2F1 | KCNN4 3942/4885KCNA5 781/4885L3MBTL1 1998/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.